Tag: Weight Loss Surgery and Bariatric
GLP-1 May Mediate Effects of Gastric Bypass on CNS Activation
After Roux-en-Y, CNS activation reduced in response to food cues, GLP-1 levels significantly elevated
High Rate of Anemia Seen After Weight-Loss Surgery
Anemia much more common among patients who did not have close follow-up with weight-loss surgeon
Long-Term Weight Loss, T2DM Remission for Roux-en-Y Surgery
Twelve-year follow-up shows durability of weight loss and remission and prevention of type 2 diabetes
Intestinal Glucose Stimulation Has Anti-Incretin Effect
Insulin sensitivity lower during oral versus IV glucose administration; difference amplified in obese
Fatty Acid Remodeling Seen in T2DM Remission Post Bariatric Sx
Triglyceride disposal and acylcarnitine production during lipid overload improved with weight loss
Five Prebariatric Subtypes Identified With Specific Profiles
Subtypes correlated with different levels of eating disorder psychopathology, depression, quality of life
Subcutaneous Exendin Treats Post-Bariatric Hypoglycemia
Injections well tolerated with no adverse effects reported
Marrow Fat May Affect Bone Mass After Roux-en-Y Gastric Bypass
Negative independent association seen for marrow fat and bone mineral density changes
Mortality Down Only for Gastric Bypass Patients With Diabetes
RYGB patients without diabetes did not have significantly improved mortality compared to controls
Bariatric Surgery Delay Can Result in Worse Outcomes
Best results seen for those with preoperative BMI of less than 40 kg/m², researchers say
